伴脑脊液蛋白升高的HARS1基因变异肌萎缩侧索硬化:1例报告及文献复习OA
HARS1 gene variant-associated amyotrophic lateral sclerosis with elevated cerebrospinal fluid protein:A case report and literature review
目的:报道1例携带HARS1基因变异并伴脑脊液蛋白升高的散发型肌萎缩侧索硬化(amyotrophic lateral sclerosis,ALS)患者的临床资料,探讨ALS患者脑脊液蛋白改变的临床意义,并就本例HARS1基因变异伴脑脊液蛋白升高进行讨论. 方法:对1例ALS患者的临床表现、电生理、影像学、脑脊液及基因检测结果进行报道,并结合文献复习及分析. 结果:患者为中年女性,持续进展性病程,以肢体进行性无力为主要表现,伴构音障碍及舌肌萎缩,存在腱反射亢进及病理征阳性.脑脊液检查显示蛋白升高,肌电图提示广泛神经源性损害,影像学检查提示皮质脊髓束受累,基因检测发现HARS1 c.210G>A(p.Met70Ile)杂合变异,临床综合诊断为ALS.经利鲁唑片、辅酶Q10及短期激素治疗后病情平稳. 结论:本例为携带罕见HARS1变异的ALS患者,提示该基因的临床表型谱可能较既往报道更为广泛.患者脑脊液蛋白轻度升高,主要反映血脑屏障功能障碍而非免疫炎症反应.HARS1变异在本例病例报道中可能具有致病、修饰或偶然携带的作用,尚需进一步功能学研究和病例积累验证.脑脊液蛋白轻度升高在ALS中并不少见,现阶段不能据此推断其与HARS1变异存在特异关联;二者可能为独立并存,或通过共同的神经退行性病理过程产生间接联系.
Objective:To report the clinical features of a sporadic amyotrophic lateral sclerosis(ALS)patient carrying the histidyl-tRNA synthetase 1(HARS1)gene variant with elevated cerebrospinal fluid(CSF)protein,to explore the clinical significance of CSF protein changes in ALS,and to discuss the association between HARS1 gene variant and elevated CSF protein in this case. Methods:Clinical manifestations,electrophysiological findings,neuroimaging,CSF analysis,and genetic testing results of one ALS patient were documented and analyzed in combination with literature review and analysis. Results:The patient was a middle-aged female,presenting with a progressive and persistent disease course.Progressive limb weakness was the primary clinical manifestation,accompanied by dysarthria and tongue muscle atrophy.She exhibited hyperactive tendon reflexes and positive pathological signs.CSF analysis revealed elevated protein levels.Electromyography demonstrated widespread neurogenic damage.Neuroimaging findings indicated involvement of the corticospinal tract.Genetic testing identified a heterozygous HARS1 c.210G>A(p.Met70Ile)variant.The clinical diagnosis was confirmed as ALS after comprehensive evaluation.Following treatment with riluzole,coenzyme Q10,and short-term corticosteroids,the patient's condition stabilized. Conclusion:This case presents an ALS patient carrying a rare HARS1 variant,suggesting that the clinical phenotypic spectrum of this gene may be broader than previously reported.The slight increase in CSF protein in this patient primarily reflects blood-brain barrier dysfunction rather than an immune-inflammatory response.The pathogenic role of the HARS1 variant in this case remains unclear—it may function as a pathogenic mutation,a disease-modifying factor,or an incidental finding requiring further functional studies and case accumulation for verification.As mild elevation of CSF protein in ALS is not uncommon,at present,it cannot be used to infer a specific association with the HARS1 variant.These two findings may coexist independently or be indirectly linked through a common neurodegenerative pathological process.
解瑞川;李静文;蒋仙国;周夏俊;高丽
三亚市人民医院神经内科,海南 三亚 572000||上海交通大学医学院附属仁济医院神经内科,上海 200127上海交通大学医学院附属仁济医院神经内科,上海 200127上海交通大学医学院附属仁济医院神经内科,上海 200127上海交通大学医学院附属仁济医院神经内科,上海 200127上海交通大学医学院附属仁济医院神经内科,上海 200127
肌萎缩侧索硬化组氨酰-转运RNA合成酶1HARS1基因脑脊液蛋白升高
Amyotrophic lateral sclerosisHistidyl-tRNA synthetase 1HARS1 geneElevated cerebrospinal fluid protein
《神经病学与神经康复学杂志》 2026 (4)
280-288,9
评论